Rhythm Pharmaceuticals buy The Goldman Sachs Group, Inc.
Start price
02.03.23
/
50%
€23.20
Target price
02.03.24
€42.45
Performance (%)
69.83%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. With a performance of 69.83% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Rhythm Pharmaceuticals | 10.244% | 10.244% | 209.589% |
iShares Core DAX® | -1.180% | 0.780% | 12.701% |
iShares Nasdaq 100 | -2.823% | -2.419% | 28.746% |
iShares Nikkei 225® | -3.908% | 1.574% | 11.146% |
iShares S&P 500 | -1.012% | -0.335% | 27.036% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€35.40
07.12.23
07.12.23
€38.96
07.12.24
07.12.24
27.12%
08:06
08:06
Stopped prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€40.80
25.01.24
25.01.24
€47.88
25.01.25
25.01.25
10.29%
08:06
08:06